Sabzali Javadov to Cardiotonic Agents
This is a "connection" page, showing publications Sabzali Javadov has written about Cardiotonic Agents.
Connection Strength
2.684
-
Khuchua Z, Glukhov AI, Strauss AW, Javadov S. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. Int J Mol Sci. 2018 Nov 04; 19(11).
Score: 0.669
-
Javadov S, Jang S, Parodi-Rull?n R, Khuchua Z, Kuznetsov AV. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? Cell Mol Life Sci. 2017 08; 74(15):2795-2813.
Score: 0.599
-
Javadov S, Escobales N. The Role of SIRT3 in Mediating Cardioprotective Effects of RAS Inhibition on Cardiac Ischemia-Reperfusion. J Pharm Pharm Sci. 2015; 18(3):547-50.
Score: 0.512
-
Escobales N, Nu?ez RE, Jang S, Parodi-Rullan R, Ayala-Pe?a S, Sacher JR, Skoda EM, Wipf P, Frontera W, Javadov S. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J Mol Cell Cardiol. 2014 Dec; 77:136-46.
Score: 0.506
-
Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007; 20(1-4):1-22.
Score: 0.294
-
Gan XT, Hunter JC, Huang C, Xue J, Rajapurohitam V, Javadov S, Karmazyn M. Ouabain increases iNOS-dependent nitric oxide generation which contributes to the hypertrophic effect of the glycoside: possible role of peroxynitrite formation. Mol Cell Biochem. 2012 Apr; 363(1-2):323-33.
Score: 0.104